Menu
GeneBe

1-150487499-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_025150.5(TARS2):c.49G>A(p.Ala17Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

TARS2
NM_025150.5 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 0.784
Variant links:
Genes affected
TARS2 (HGNC:30740): (threonyl-tRNA synthetase 2, mitochondrial) This gene encodes a member of the class-II aminoacyl-tRNA synthetase family. The encoded protein is a mitochondrial aminoacyl-tRNA synthetase. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 4. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0586071).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TARS2NM_025150.5 linkuse as main transcriptc.49G>A p.Ala17Thr missense_variant 1/18 ENST00000369064.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TARS2ENST00000369064.8 linkuse as main transcriptc.49G>A p.Ala17Thr missense_variant 1/181 NM_025150.5 P1Q9BW92-1

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152220
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000756
AC:
19
AN:
251446
Hom.:
0
AF XY:
0.0000957
AC XY:
13
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000154
AC:
225
AN:
1461892
Hom.:
0
Cov.:
31
AF XY:
0.000139
AC XY:
101
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000182
Gnomad4 OTH exome
AF:
0.000331
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152220
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000767
Hom.:
0
Bravo
AF:
0.000110
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 17, 2022This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 17 of the TARS2 protein (p.Ala17Thr). This variant is present in population databases (rs367864616, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 559355). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxFeb 09, 2022Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Uncertain significance, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 29, 2017- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 02, 2023The c.49G>A (p.A17T) alteration is located in exon 1 (coding exon 1) of the TARS2 gene. This alteration results from a G to A substitution at nucleotide position 49, causing the alanine (A) at amino acid position 17 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Combined oxidative phosphorylation defect type 21 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteMay 21, 2020A heterozygous missense variant was identified, NM_025150.4(TARS2):c.49G>A in exon 1 of 18 of the TARS2 gene. This substitution is predicted to create a minor amino acid change from an alanine to a threonine at position 17 of the protein; NP_079426.2(TARS2):p.(Ala17Thr). The alanine at this position has low conservation (100 vertebrates, UCSC), and is not situated in a known functional domain (NCBI, PDB, UniProt). In silico software predicts this variant to be tolerated (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a global population frequency of 0.008% (22 heterozygotes, 0 homozygotes) with a European sub-population frequency of 0.01%. This variant has been previously reported in ClinVar as a VUS. Based on information available at the time of curation, this variant has been classified as a VUS with LOW CLINICAL RELEVANCE. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.50
Cadd
Benign
15
Dann
Uncertain
0.98
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.70
T;T;T
M_CAP
Benign
0.0032
T
MetaRNN
Benign
0.059
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.6
L;L;.
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.74
N;N;.
REVEL
Benign
0.013
Sift
Benign
0.10
T;T;.
Sift4G
Benign
0.38
T;T;T
Polyphen
0.0020
.;B;.
Vest4
0.15
MVP
0.10
MPC
0.41
ClinPred
0.039
T
GERP RS
2.1
Varity_R
0.040
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs367864616; hg19: chr1-150459975; COSMIC: COSV99057826; COSMIC: COSV99057826; API